WPA
West Paces Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-85
| Closed | -$2.89K | – | 288 |
|
|
2025
Q1 | $2.89K | Hold |
85
| – | – | ﹤0.01% | 415 |
|
|
2024
Q4 | $3.35K | Hold |
85
| – | – | ﹤0.01% | 409 |
|
|
2024
Q3 | $3.99K | Hold |
85
| – | – | ﹤0.01% | 395 |
|
|
2024
Q2 | $4.59K | Hold |
85
| – | – | ﹤0.01% | 394 |
|
|
2024
Q1 | $5.79K | Hold |
85
| – | – | ﹤0.01% | 395 |
|
|
2023
Q4 | $5.32K | Hold |
85
| – | – | ﹤0.01% | 405 |
|
|
2023
Q3 | $3.86K | Hold |
85
| – | – | ﹤0.01% | 403 |
|
|
2023
Q2 | $4.77K | Hold |
85
| – | – | ﹤0.01% | 424 |
|
|
2023
Q1 | $3.85K | Hold |
85
| – | – | ﹤0.01% | 441 |
|
|
2022
Q4 | $3.46K | Buy |
85
+50
| +143% | +$2.03K | ﹤0.01% | 415 |
|
|
2022
Q3 | $2.29K | Hold |
35
| – | – | ﹤0.01% | 428 |
|
|
2022
Q2 | $2.13K | Hold |
35
| – | – | ﹤0.01% | 489 |
|
|
2022
Q1 | $2.2K | Hold |
35
| – | – | ﹤0.01% | 481 |
|
|
2021
Q4 | $2.65K | Buy |
+35
| New | +$2.65K | ﹤0.01% | 496 |
|